Profile data is unavailable for this security.
About the company
Synthaverse SA formerly known as Biomed Lublin Wytwornia Surowic i Szczepionek SA is a Poland-based company operating in the Life Science industry, dealing primarily with the production of medicines. The Company focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The Company offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The Company supplies its products to 50 countries around the world.
- Revenue in PLN (TTM)53.75m
- Net income in PLN-6.06m
- Incorporated2010
- Employees231.00
- LocationSynthaverse SAul. Uniwersytecka 10LUBLIN 20-029PolandPOL
- Phone+48 815338221
- Fax+48 815338060
- Websitehttps://synthaverse.pl/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assertio Holdings Inc | 487.35m | -102.63m | 281.75m | 58.00 | -- | 0.7505 | 35.98 | 0.5781 | -4.71 | -4.71 | 20.93 | 16.49 | 0.4611 | 1.35 | 1.47 | 2,368,138.00 | -9.71 | -15.74 | -17.07 | -24.19 | 68.16 | 82.29 | -21.06 | -42.01 | 1.43 | -- | 0.2702 | -- | -17.83 | -11.45 | 93.50 | -- | -- | -- |
| Stella Pharma Corp | 22.51m | -6.49m | 282.31m | 43.00 | -- | 4.51 | -- | 12.54 | -8.21 | -8.21 | 28.47 | 79.22 | 0.1966 | 0.0944 | 2.91 | 22,529,260.00 | -5.67 | -16.41 | -5.96 | -18.19 | 87.88 | 87.03 | -28.83 | -176.16 | 13.81 | -45.69 | 0.226 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| Fabtech Technologies Ltd | -3.92bn | -3.92bn | 282.94m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.46 | -- | 70.67 | -- | -- | -- |
| Synthaverse SA | 53.75m | -6.06m | 283.76m | 231.00 | -- | 2.03 | 43.97 | 5.28 | -0.0827 | -0.0827 | 0.7543 | 1.84 | 0.1807 | 1.41 | 2.16 | 232,688.30 | -2.04 | 3.30 | -2.36 | 3.91 | 61.45 | 57.46 | -11.27 | 10.33 | 0.742 | -0.5519 | 0.3923 | -- | 22.44 | 12.91 | 58.68 | 24.91 | 120.32 | -- |
| Polypid Ltd | 0.00 | -121.40m | 286.14m | 57.00 | -- | 4.80 | -- | -- | -2.98 | -2.98 | 0.00 | 0.9237 | 0.00 | -- | -- | 0.00 | -147.37 | -90.05 | -241.51 | -109.86 | -- | -- | -- | -- | -- | -22.38 | 0.1359 | -- | -- | -- | -21.61 | -- | -38.71 | -- |
| Bangkok Lab and Cosmetic PCL | 191.93m | 21.53m | 286.50m | 1.11k | 13.31 | 1.49 | 9.97 | 1.49 | 0.3141 | 0.3141 | 2.80 | 2.81 | 0.732 | 2.74 | 4.66 | 1,517,711.00 | 8.36 | 7.24 | 10.41 | 12.57 | 30.39 | 28.80 | 11.42 | 8.08 | 1.44 | 31.98 | 0.1135 | -- | 10.73 | 5.31 | 17.85 | 142.44 | 16.91 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 1.03bn | 10.57m | 290.11m | 2.49k | 26.82 | 0.5197 | 4.44 | 0.2812 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 882,003.30 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Holder | Shares | % Held |
|---|---|---|
| AgioFunds TFI SAas of 28 Jan 2026 | 421.42k | 0.56% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 1.30k | 0.00% |
